TRX-818 capsules
Sponsors
TaiRx, Inc.
Conditions
Advanced CancerCarcinoma
Phase 1
A Safety and Pharmacokinetic Study of TRX-818 Administered Orally to Patients With Advanced Cancer
CompletedNCT02507544
Start: 2015-09-30End: 2019-05-20Updated: 2020-05-21
Safety and Pharmacokinetic Study of TRX-818 in Asian Solid Tumor Patients
CompletedNCT02703298
Start: 2016-03-25End: 2018-05-03Updated: 2019-03-28